Nasdaq

Futura Granted FDA Approval For OTC Marketing Of MED3000 Gel For Erectile Dysfunction

(RTTNews) - Futura Medical plc (FUM.L) announced on Tuesday that the US Food and Drug Administration or FDA has granted over-the-counter sale or OTC marketing authorization for its MED3000 topical gel ...
AOL

There's a New Over-the-Counter ED Drug. Should You Be Taking It?

WHEN YOU’RE DEALING with erectile dysfunction, you usually have to make an appointment with your doctor to get treated. But, soon, you’ll be able to pick up medication at your local pharmacy without a ...
Healio

Topical gel for erectile dysfunction shows promise in phase 3 trial

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a confirmatory study, MED3000 was associated with ...
Healio

FDA grants OTC authorization to topical gel for erectile dysfunction

Please provide your email address to receive an email when new articles are posted on . MED3000 previously showed significant improvement in erectile function in a phase 3 trial. It is the first ...
Business Wire

Highly positive FM71 Phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to submit for FDA marketing authorization

FM71 Trial Design FM71 is a multi-center, randomized, open-label, home use, parallel group, clinical investigation of topically-applied MED3000 gel compared to oral tadalafil (5mg) tablets for the ...
Gizmodo

There’s Now an Over-the-Counter Gel for Erectile Dysfunction

Futura Medica's Eroxon will be the first over-the-counter topical gel for ED marketed in the US, though it could take a while before it hits the shelves. Reading time 2 minutes An easily accessible ...
MedPage Today

Could a 'Placebo' Become the Next Big ED Treatment?

Regulators in Europe are close to approving an unusual over-the-counter treatment for erectile dysfunction (ED): a non-medicated gel that once was used as a placebo, but turned out to work just as ...
Yahoo Finanzas

US FDA Grants for Over-the-Counter Marketing Authorization to Futura for Fast-Acting Topical Gel, MED3000, to Treat Erectile Dysfunction

- Company also announced that it raised proceeds of £4,375,000 to fund future commercialization of MED3000 via a warrant exercise by a large institutional shareholder - GUILDFORD, England, June 12, ...
London South East

Futura Medical Regulatory News

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, is pleased to provide an update on good progress with its ...